IL2 and neoplasm: Utilizing bilateral flank tumor model, it has been reported that the intratumoral injection of the membrane-tethered IL-2-armed oncolytic virus (vvDD-mIL2) plus CpG oligodeoxynucleotide can trigger systemic immunization.